Creades

Creades is a Swedish publicly listed investment company and long-term active owner, not a biotechnology, pharmaceutical, or healthcare operating company. The firm invests in small and medium-sized listed and unlisted businesses and focuses on value creation through engaged ownership, operational development, and structural or financial change initiatives. Creades was spun off from Investment AB Öresund and manages a concentrated portfolio across multiple sectors rather than developing therapeutic products. For biotech analyst purposes, Creades is best understood as an investor or holding company that may own stakes in healthcare-related assets, but it does not itself appear to run a drug pipeline or life sciences platform.